Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3455-3458
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3455
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3455
Table 1 Selection of optimal concentration of PASODN
Clones | Concentration of PASODN (μmol/L) | |||||
0 | 1 | 2.5 | 5 | 10 | 20 | |
Mean | 64.7 | 51.5 | 41.0 | 24.7 | 11.1 | 8.4 |
Inhibitive rate (%) | 0 | 20.4 | 36.6 | 61.8 | 82.8 | 87.0 |
Table 2 Colony-forming efficiency in each group (mean ± SD)
PASODN(10 μmol/L) | PMSODN(10 μmol/L) | PBS(same volume) | |
Mean±SD | 41.2 ± 5.5 | 196.3 ± 13.5 | 202.8 ± 8.5 |
Efficiency (%) | 10.3 | 49.1 | 50.7 |
vs PASODN | P < 0.01 | P < 0.01 |
Table 3 Variation of telomerase activity (mean ± SD)
Group | SA | P |
PASODN | 0.18 ± 0.12 | |
PMSODN | 1.89 ± 0.24 | < 0.01 |
PBS | 1.98 ± 0.25 | < 0.01 |
Table 4 Effect of PASODN on LS-174T cell cycle
Groups | G0/G1 | G2/M | S |
Control | 49.91 | 21.79 | 28.30 |
PASODN | 53.20 | 11.25 | 35.55 |
- Citation: Wang XS, Wang K, Li X, Fu SB. Effects of phosphorothioate anti-sense oligodeoxynucleotides on colorectal cancer cell growth and telomerase activity. World J Gastroenterol 2004; 10(23): 3455-3458
- URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3455.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3455